Back to Search
QIN RYAN, MD, PHD
MD, PHD
Internal Medicine Physician
NPI: 1629239793Individual
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
066321(PA)
Research & Publications (6)
FDA drug approval summary: lapatinib in combination with capecitabine for previously treated metastatic breast cancer that overexpresses HER-2.
PMID 18849320·Oncologist·2008
3-trial
Phase I and pharmacokinetic study of MS-275, a histone deacetylase inhibitor, in patients with advanced and refractory solid tumors or lymphoma.
PMID 15851766·J Clin Oncol·2005
3-trial
Phase I trial of MS-275, a histone deacetylase inhibitor, administered weekly in refractory solid tumors and lymphoid malignancies.
PMID 17875771·Clin Cancer Res·2007
3-trial
Factors affecting the pharmacokinetic profile of MS-275, a novel histone deacetylase inhibitor, in patients with cancer.
PMID 16583304·Invest New Drugs·2006
3-trial
Histone deacetylase inhibitor pharmacodynamic analysis by multiparameter flow cytometry.
PMID 16254255·Ann Clin Lab Sci·2005
8-other
Fluorodeoxyglucose positron emission tomography in the presence of cardiac metastases.
PMID 14663321·Clin Nucl Med·2003
5-case
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2306 FALLING CREEK RD
SILVER SPRING, MD 20904 - Phone
- (301) 388-0937
Quick Facts
- NPI
- 1629239793
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 6
Are you this provider?
Claim Your Profile